TacticScaleWhat Covista Does & How It Makes Money (CVSA)
Updated October 2026 · reflects Covista's latest reported financials
US healthcare education company running nursing, medical, and veterinary schools. It earns tuition and fees from students enrolled in its degree and certificate programs at its nursing, online, medical, and veterinary institutions.
How Covista makes money
It earns tuition and fees from students enrolled in its degree and certificate programs at its nursing, online, medical, and veterinary institutions.
What Covista does
Covista Inc., known as Adtalem Global Education Inc. until February 2026, is a Chicago-based provider of postsecondary healthcare education. It reports three segments: Chamberlain (nursing and health professions), Walden (mostly online graduate and undergraduate programs in fields such as counseling, psychology, public health, social work, business, and IT), and Medical and Veterinary, which covers the American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company operates in the United States, Barbados, St. Kitts, and St. Maarten. It offers bachelor's, master's, and doctoral degrees plus online certificates, which positions it as a large supplier of trained workers for the healthcare field. It was incorporated in 1987.
Products & services
- Chamberlain University
- Walden University
- American University of the Caribbean School of Medicine
- Ross University School of Medicine
- Ross University School of Veterinary Medicine
What is Covista worth?
On an owner-earnings DCF, Covista's most-likely value is about $264 versus a recent price near $129 (104% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$122) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Strategic Education (STRA) · Perdoceo Education (PRDO) · Envista (NVST) · Stride (LRN) · Laureate Education (LAUR)